- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 451/04 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamineCyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropaneCyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring system
Patent holdings for IPC class C07D 451/04
Total number of patents in this class: 263
10-year publication summary
|
22
|
19
|
25
|
28
|
18
|
20
|
23
|
8
|
5
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 408 |
13 |
| Remix Therapeutics Inc. | 84 |
10 |
| Skyhawk Therapeutics, Inc. | 147 |
9 |
| Novartis AG | 10279 |
8 |
| Purdue Pharma L.P. | 493 |
8 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 872 |
8 |
| Shionogi & Co., Ltd. | 873 |
7 |
| Janssen Pharmaceutica N.V. | 3175 |
6 |
| Curza Global, LLC | 27 |
5 |
| Rigel Pharmaceuticals, Inc. | 507 |
5 |
| University of Utah Research Foundation | 1858 |
5 |
| Bristol-myers Squibb Company | 4725 |
4 |
| Merck Patent GmbH | 5725 |
4 |
| BioMarin Pharmaceutical Inc. | 400 |
4 |
| Enanta Pharmaceuticals, Inc. | 430 |
4 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 375 |
4 |
| The University of Edinburgh | 27 |
4 |
| Shanghai Hansoh Biomedical Co., Ltd. | 353 |
4 |
| Nxera Pharma UK Limited | 187 |
4 |
| Glaxosmithkline Intellectual Property Development Limited | 777 |
3 |
| Other owners | 144 |